Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart

被引:57
|
作者
Hilfiker-Kleiner, D
Hilfiker, A
Kaminski, K
Schaefer, A
Park, JK
Michel, K
Quint, A
Yaniv, M
Weitzman, JB
Drexler, H
机构
[1] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany
[2] Hannover Med Sch, Dept Cardiovasc Surg, Hannover, Germany
[3] Hannover Med Sch, Dept Nephrol, Hannover, Germany
[4] Inst Pasteur, Unit Gene Express & Dis, Paris, France
关键词
angiogenesis; apoptosis; hypertrophy;
D O I
10.1161/CIRCULATIONAHA.104.518472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - The Jun family of activator protein 1 (AP-1) transcription factors (c-Jun, JunB, and JunD) is involved in fundamental biological processes such as proliferation, apoptosis, tumor angiogenesis, and hypertrophy. The role of individual AP-1 transcription factors in the stressed heart is not clear. In the present study we analyzed the role of JunD in survival, hypertrophy, and angiogenesis in the pressure-overloaded mouse heart after thoracic aortic constriction. Methods and Results - Mice lacking JunD (knockout [KO]) showed increased mortality and enhanced cardiomyocyte apoptosis and fibrosis associated with increased levels of hypoxia-induced factor-1 alpha, vascular endothelial growth factor (VEGF), p53, and Bax protein and reduced levels of Bcl-2 protein after 7 days of severe pressure overload compared with wild-type (WT) siblings. Cardiomyocyte hypertrophy in surviving KO mice was enhanced compared with that in WT mice. Chronic moderate pressure overload for 12 weeks caused enhanced left ventricular hypertrophy in KO mice, and survival and interstitial fibrosis were comparable with WT mice. Cardiac function, 12 weeks after operation, was comparable among shams and pressure-overloaded mice of both genotypes. In addition, KO mice exposed to chronic pressure overload showed higher cardiac capillary density associated with increased protein levels of VEGF. Conclusions - Thus, JunD limits cardiomyocyte hypertrophy and protects the pressure-overloaded heart from cardiac apoptosis. These beneficial effects of JunD, however, are associated with antiangiogenic properties.
引用
收藏
页码:1470 / 1477
页数:8
相关论文
共 50 条
  • [11] Rethinking Protein Acetylation in Pressure Overload-Induced Heart Failure
    Scott, Iain
    Sack, Michael N.
    CIRCULATION RESEARCH, 2020, 127 (08) : 1109 - 1111
  • [12] EFFECT OF PITAVASTATIN ON PRESSURE OVERLOAD-INDUCED HEART FAILURE IN MICE
    Kameda, Yoshihito
    Hasegawa, Hiroshi
    Kubota, Akihiko
    Tadokoro, Hiroyuki
    Kobayashi, Yoshio
    Takano, Hiroyuki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1062 - E1062
  • [13] IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
    Dai, Jia
    Shen, Di-Fei
    Bian, Zhou-Yan
    Zhou, Heng
    Gan, Hua-Wen
    Zong, Jing
    Deng, Wei
    Yuan, Yuan
    Li, FangFang
    Wu, Qing-Qing
    Gao, Lu
    Zhang, Rui
    Ma, Zhen-Guo
    Li, Hong-Liang
    Tang, Qi-Zhu
    PLOS ONE, 2013, 8 (01):
  • [14] Dipeptidyl Peptidase 4 Promotes Pressure Overload-Induced Heart Failure through enhancing Antigen Presentation
    Yu, Kun
    Liao, Minyu
    Tang, Du
    Ling, Wang
    Zhu, Wenqiang
    Liu, Xiaohui
    Zhong, Jixin
    Rao, Xiaoquan
    CIRCULATION, 2024, 150
  • [15] Chronic Stress Promotes the Progression of Pressure Overload-Induced Cardiac Dysfunction Through Inducing More Apoptosis and Fibrosis
    Liu, W.
    Wang, X.
    Mei, Z.
    Gong, J.
    Gao, X.
    Zhao, Y.
    Ma, J.
    Xie, F.
    Qian, L.
    PHYSIOLOGICAL RESEARCH, 2015, 64 (03) : 325 - 334
  • [16] Targeting the adipose tissue: heart crosstalk in pressure overload-induced heart failure
    Tual-Chalot, Simon
    Stellos, Konstantinos
    CARDIOVASCULAR RESEARCH, 2022, 118 (08) : 1854 - 1856
  • [17] Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice
    Weng, Li-qing
    Zhang, Wen-bin
    Ye, Yong
    Yin, Pei-pei
    Yuan, Jie
    Wang, Xing-xu
    Kang, Le
    Jiang, Sha-sha
    You, Jie-yun
    Wu, Jian
    Gong, Hui
    Ge, Jun-bo
    Zou, Yun-zeng
    ACTA PHARMACOLOGICA SINICA, 2014, 35 (08) : 1005 - 1014
  • [18] Effects of MitoQ on Mitochondrial Function in Pressure Overload-Induced Heart Failure
    O'Connell, Kelly Anne
    Dabkowski, Erinne R.
    Faustino, Rogerio
    Xu, Wenhong
    Galvao, Tatiana
    Stanley, William C.
    FASEB JOURNAL, 2012, 26
  • [19] Cardiac Microvascular Endothelial Cells in Pressure Overload-Induced Heart Disease
    Trenson, Sander
    Hermans, Hadewich
    Craps, Sander
    Pokreisz, Peter
    de Zeeuw, Pauline
    Van Wauwe, Jore
    Gillijns, Hilde
    Veltman, Denise
    Wei, Fangfei
    Caluwe, Ellen
    Gijsbers, Rik
    Baatsen, Pieter
    Staessen, Jan A.
    Ghesquiere, Bart
    Carmeliet, Peter
    Rega, Filip
    Meuris, Bart
    Meyns, Bart
    Oosterlinck, Wouter
    Duchenne, Jurgen
    Goetschalckx, Kaatje
    Voigt, Jens-Uwe
    Herregods, Marie-Christine
    Herijgers, Paul
    Luttun, Aernout
    Janssens, Stefan
    CIRCULATION-HEART FAILURE, 2021, 14 (01) : 97 - 111
  • [20] Regulation of apoptotic genes and markers in pressure overload-induced heart failure
    Philipp, S
    Höhnel, K
    Hamet, P
    Dietz, R
    Willenbrock, R
    Lutz, J
    EUROPEAN HEART JOURNAL, 2001, 22 : 398 - 398